Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tetracosactide versus triamcinolone for rotator cuff tendinopathy
IRCT20240110060673N1Phase 4Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Mar 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of tetracosactide hexaacetate and triamcinolone acetonide in shoulder tendinopathy (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Pain intensity change and Shoulder pain and function change. Started Mar 2024; status: completed.
02
Drugs
tetracosactide hexaacetatetriamcinolone acetonide
03
Conditions
shoulder tendinopathy
Beyond the preview
Go deeper on IRCT20240110060673N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240110060673N1.